VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TMO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TMOThermo Fisher Scientific Inc.
$513.03$190.7B
Overview & Verdict
OverviewShould I Buy?
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTMOQuarterly Financials

Thermo Fisher Scientific Inc. (TMO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Thermo Fisher Scientific Inc. (TMO) quarterly income statement — complete revenue, gross profit & net income history

TMO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue11.01B12.21B11.12B10.86B10.36B11.39B10.6B10.54B10.35B10.89B10.57B10.69B
Revenue Growth %6.18%7.2%4.94%2.98%0.18%4.68%0.23%-1.37%-3.41%-4.93%-0.96%-2.58%
Cost of Goods Sold6.53B7.58B6.47B6.81B6.12B6.93B6.25B6.2B6.13B6.93B6.24B6.42B
COGS % of Revenue59.33%62.05%58.17%62.71%59.04%60.8%59.02%58.79%59.24%63.69%59.03%60.05%
Gross Profit4.48B4.64B4.65B4.05B4.25B4.47B4.34B4.34B4.22B3.95B4.33B4.27B
Gross Margin %40.67%37.95%41.83%37.29%40.96%39.2%40.98%41.21%40.76%36.31%40.97%39.95%
Gross Profit Growth %5.44%3.78%7.11%-6.81%0.66%13%0.25%1.76%0.79%-4.91%0.25%-6.91%
Operating Expenses2.61B2.33B2.71B2.13B2.4B2.2B2.43B2.59B2.5B1.96B2.36B2.49B
OpEx % of Revenue23.74%19.11%24.38%19.63%23.21%19.3%22.9%24.53%24.14%18.02%22.3%23.28%
Selling, General & Admin1.8B1.98B2.37B1.78B2.06B1.82B2.08B2.25B2.17B1.64B2.04B2.14B
SG&A % of Revenue16.34%16.18%21.26%16.39%19.91%16.02%19.64%21.32%20.94%15.02%19.28%20.05%
Research & Development336M357M347M352M342M374M346M339M331M327M319M345M
R&D % of Revenue3.05%2.92%3.12%3.24%3.3%3.28%3.26%3.22%3.2%3%3.02%3.23%
Other Operating Expenses1000K00000000000
Operating Income1.86B2.3B1.94B1.92B1.84B2.27B1.92B1.76B1.72B1.99B1.97B1.78B
Operating Margin %16.93%18.85%17.47%17.66%17.75%19.9%18.08%16.68%16.63%18.29%18.67%16.67%
Operating Income Growth %1.25%1.5%1.41%9.04%6.98%13.91%-2.94%-1.29%0.94%0.3%12.35%-8.24%
EBITDA2.29B3.03B2.61B2.6B2.54B3.01B2.66B2.55B2.56B2.83B2.83B2.64B
EBITDA Margin %20.84%24.8%23.43%23.97%24.56%26.42%25.06%24.17%24.71%26%26.74%24.67%
EBITDA Growth %-9.9%0.63%-1.88%2.12%-0.43%6.36%-6.05%-3.34%-0.27%-0.11%8.94%-5.08%
D&A (Non-Cash Add-back)430M727M663M685M705M742M740M790M836M839M853M855M
EBIT1.88B2.49B2.17B2.11B1.92B2.33B2.17B2.19B1.95B2.18B2.16B1.76B
Net Interest Income-121M-107M-113M-107M-100M-157M-147M-126M-84M-135M-147M-148M
Interest Income233M258M234M297M203M227M277M295M279M309M246M178M
Interest Expense354M365M347M404M303M384M424M421M363M444M393M326M
Other Income/Expense-129M-179M-115M-206M-234M-294M-188M-77M-108M-252M-226M-367M
Pretax Income1.73B2.12B1.83B1.71B1.61B1.97B1.73B1.68B1.61B1.74B1.75B1.41B
Pretax Margin %15.76%17.38%16.44%15.76%15.5%17.32%16.3%15.95%15.58%15.97%16.53%13.23%
Income Tax70M153M207M92M95M150M99M128M281M133M53M52M
Effective Tax Rate %4.04%7.21%11.32%5.38%5.92%7.6%5.73%7.61%17.43%7.65%3.03%3.68%
Net Income1.65B1.98B1.62B1.62B1.51B1.83B1.63B1.55B1.33B1.63B1.72B1.36B
Net Margin %15%16.17%14.53%14.9%14.54%16.06%15.38%14.69%12.84%14.97%16.22%12.74%
Net Income Growth %9.56%7.92%-0.86%4.46%13.48%12.27%-4.96%13.74%3.03%3.43%14.72%-18.21%
Net Income (Continuing)1.66B1.97B1.62B1.62B1.51B1.82B1.63B1.55B1.33B1.61B1.7B1.36B
Discontinued Operations000000000000
Minority Interest121M129M129M91M95M87M107M103M107M107M136M163M
EPS (Diluted)4.435.214.274.283.984.784.244.043.464.204.423.51
EPS Growth %11.31%9%0.71%5.94%15.03%13.81%-4.07%15.1%4.22%4.74%16.93%-16.82%
EPS (Basic)4.445.224.284.283.994.794.274.053.484.214.443.53
Diluted Shares Outstanding373M377M378M378M379M383M384M383M384M388M388M388M
Basic Shares Outstanding372M376M378M378M378M382.85M382M382M382M387M386M386M
Dividend Payout Ratio9.81%8.2%10.09%10.02%9.89%8.14%9.2%9.63%10.17%8.34%7.87%9.92%